Chemical Compound

Asciminib; 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-; N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-3-pyridinecarboxamide; 3-Pyridinecarboxamide N-[4-

CAS Registry Number 1492952-76-7
返回搜索 申请报价
Asciminib; 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-; N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-3-pyridinecarboxamide; 3-Pyridinecarboxamide N-[4- 结构式
Primary record

Asciminib; 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-; N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-3-pyridinecarboxamide; 3-Pyridinecarboxamide N-[4-

库存
2,575 克
纯度
99.0 %
CAS
1492952-76-7

化合物标识与属性

CAS
1492952-76-7
PubChem CID
72165228
SMILES
C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4
Canonical SMILES
O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2ccn[nH]2)c1

名称与同义词

  • asciminib
  • Scemblix
  • ABL-001
  • asciminibum
  • Asciminib free base
  • Asciminib?
  • ABL001
  • 1492952-76-7
  • Asciminib [USAN]
  • Example 9
  • ABL001-NX
  • NVP-ABL001
  • Asciminib (Standard)
  • Asciminib (ABL001)
  • Asciminib hydrochloride
  • ASCIMINIB [INN]
  • RefChem:58302
  • Asciminib (USAN/INN)
  • ASCIMINIB [WHO-DD]
  • ABL001-AAA
  • L1F3R18W77
  • C20H18ClF2N5O3
  • UNII-L1F3R18W77
  • VOVZXURTCKPRDQ-CQSZACIVSA-N
  • ABL-001-NX
  • GTPL8962
  • orb1302024
  • CHEMBL4208229
  • SCHEMBL15388306
  • SCHEMBL15388502
  • TQP0925
  • 1492952-76-7 (free base)
  • EX-A3030
  • BDBM50459091
  • MFCD31560488
  • NSC789925
  • s8555
  • Benzenesulfinic acid,2-amino-5-nitro
  • AKOS032944882
  • ZINC150275965
  • AT30330
  • CCG-269232
  • compound 1 [PMID: 30137981]
  • CS-7655
  • DB12597
  • EBC-171024
  • HY-104010R
  • NSC-789925
  • BA166957
  • BS-15538
  • DA-50736
  • SY041029
  • HY-104010
  • NS00073443
  • J3.737.613B
  • D11403
  • (R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide
  • A910986
  • Q27074535
  • 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
  • N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
  • B0084-007699
  • 3-Pyridinecarboxamide, N-(4-(chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxy-1-pyrrolidinyl)-5-(1H-pyrazol-3-yl)-
  • (R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)nicotinamide
  • N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-3-yl)pyridine-3-carboxamide
  • (R)-N-(4-(Chloro difluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide
  • (R)-N-[4-(Chlorodifluoromethoxy)phenyl]-6-(3-hydroxy-1-pyrrolidinyl)-5-(3-pyrazolyl)nicotinamide
  • Asciminib; 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-; N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-3-pyridinecarboxamide; 3-Pyridinecarboxamide N-[4-
  • AY7
  • N-(4-(chloro(difluoro)methoxy)phenyl)-6-((3R)-3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
  • N-(4-(CHLORODIFLUOROMETHOXY)PHENYL)-6-((3R)-3- HYDROXYPYRROLIDIN-1-YL)-5-(1H-PYRAZOL-3-YL)PYRIDINE- 3-CARBOXAMIDE
  • N-(4-(chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
  • N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide